These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. In the era of the universal use of statins dyslipidemia's are still common in heart transplant recipients: a cross-sectional study. Zakliczynski M; Boguslawska J; Wojniak E; Zakliczynska H; Ciesla D; Nozynski J; Szygula-Jurkiewicz B; Zeglen S; Zembala M Transplant Proc; 2011 Oct; 43(8):3071-3. PubMed ID: 21996228 [TBL] [Abstract][Full Text] [Related]
11. Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy. Hedman M; Pahlman R; Sundvall J; Ehnholm C; Syvänne M; Jokinen E; Jauhiainen M; Holmberg C; Antikainen M Pediatr Transplant; 2007 Aug; 11(5):481-90. PubMed ID: 17631015 [TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864 [TBL] [Abstract][Full Text] [Related]
13. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy. Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806 [TBL] [Abstract][Full Text] [Related]
14. Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts. Mahesh B; Leong HS; Nair KS; McCormack A; Sarathchandra P; Rose ML Transplantation; 2010 Jul; 90(1):4-13. PubMed ID: 20463646 [TBL] [Abstract][Full Text] [Related]
15. Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy. Singh N; Heggermont W; Fieuws S; Vanhaecke J; Van Cleemput J; De Geest B J Heart Lung Transplant; 2015 Nov; 34(11):1376-84. PubMed ID: 26198441 [TBL] [Abstract][Full Text] [Related]
16. Influence of metabolic syndrome on development of cardiac allograft vasculopathy in the transplanted heart. Sánchez-Gómez JM; Martínez-Dolz L; Sánchez-Lázaro I; Almenar L; Sánchez-Lacuesta E; Muñoz-Giner B; Portolés M; Rivera M; Valera-Román A; González-Juanatey JR; Tejada-Ponce D; Agüero J; Buendía F; Salvador A Transplantation; 2012 Jan; 93(1):106-11. PubMed ID: 22134367 [TBL] [Abstract][Full Text] [Related]
17. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl. Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129 [TBL] [Abstract][Full Text] [Related]
18. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients. Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420 [TBL] [Abstract][Full Text] [Related]